72 related articles for article (PubMed ID: 9425956)
1. Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis.
Sinha BK; Tokar EJ; Bushel PR
Front Genet; 2020; 11():775. PubMed ID: 32765594
[TBL] [Abstract][Full Text] [Related]
2. Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
Sinha BK; van 't Erve TJ; Kumar A; Bortner CD; Motten AG; Mason RP
Free Radic Biol Med; 2017 Dec; 113():406-412. PubMed ID: 29079526
[TBL] [Abstract][Full Text] [Related]
3. Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study.
Amoroso L; Erminio G; Makin G; Pearson ADJ; Brock P; Valteau-Couanet D; Castel V; Pasquet M; Laureys G; Thomas C; Luksch R; Ladenstein R; Haupt R; Garaventa A;
Cancer Res Treat; 2018 Jan; 50(1):148-155. PubMed ID: 28324923
[TBL] [Abstract][Full Text] [Related]
4. PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.
Shah DK; Balthasar JP
Int J Pharm; 2014 Apr; 465(1-2):228-38. PubMed ID: 24508555
[TBL] [Abstract][Full Text] [Related]
5. Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.
Shah DK; Balthasar JP
J Pharmacokinet Pharmacodyn; 2014 Feb; 41(1):55-69. PubMed ID: 24368689
[TBL] [Abstract][Full Text] [Related]
6. Initial testing of topotecan by the pediatric preclinical testing program.
Carol H; Houghton PJ; Morton CL; Kolb EA; Gorlick R; Reynolds CP; Kang MH; Maris JM; Keir ST; Watkins A; Smith MA; Lock RB
Pediatr Blood Cancer; 2010 May; 54(5):707-15. PubMed ID: 20017204
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy for esophageal cancer.
Neuner G; Patel A; Suntharalingam M
Gastrointest Cancer Res; 2009 Mar; 3(2):57-65. PubMed ID: 19461907
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
Zamboni WC; Ramalingam S; Friedland DM; Edwards RP; Stoller RG; Strychor S; Maruca L; Zamboni BA; Belani CP; Ramanathan RK
Clin Cancer Res; 2009 Feb; 15(4):1466-72. PubMed ID: 19190127
[TBL] [Abstract][Full Text] [Related]
9. A review of topotecan in combination chemotherapy for advanced cervical cancer.
Robati M; Holtz D; Dunton CJ
Ther Clin Risk Manag; 2008 Feb; 4(1):213-8. PubMed ID: 18728710
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topotecan plus vincristine and doxorubicin in children with recurrent/refractory rhabdomyosarcoma.
Meazza C; Casanova M; Zaffignani E; Luksch R; Podda M; Favini F; Catania S; Biassoni V; Morosi C; Ferrari A
Med Oncol; 2009; 26(1):67-72. PubMed ID: 18679836
[TBL] [Abstract][Full Text] [Related]
11. Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in mice.
Chen J; Lu Q; Balthasar JP
J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6):829-47. PubMed ID: 17885736
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer.
Levitt NC; Propper DJ; Madhusudan S; Braybrooke JP; Echeta C; Te Poele R; Davies SL; Flanagan E; Hickson ID; Joel S; Ganesan TS
Br J Cancer; 2005 Jul; 93(1):60-9. PubMed ID: 15956976
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma.
Lesimple T; Hassel MB; Gédouin D; Seigneuret E; Carsin B; Hamlat A; Riffaud L; Simon H; Malhaire JP; Guégan Y
J Neurooncol; 2003 Nov; 65(2):141-8. PubMed ID: 14686734
[TBL] [Abstract][Full Text] [Related]
14. Review of phase I clinical studies with topotecan.
Rowinsky EK; Verweij J
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-3-S20-10. PubMed ID: 9425956
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
16. Topotecan in the treatment of gynecologic cancer.
Coleman RL; Miller DS
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-55-S20-63. PubMed ID: 9425962
[TBL] [Abstract][Full Text] [Related]
17. Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
Saltz L; Janik JE
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-26-S5-30. PubMed ID: 9122740
[TBL] [Abstract][Full Text] [Related]
18. Topotecan in the treatment of non-small cell lung cancer.
Perez-Soler R
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959
[TBL] [Abstract][Full Text] [Related]
19. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
